Anticancer mechanisms of metformin: A review of the current evidence
- 1 August 2020
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 254, 117717
- https://doi.org/10.1016/j.lfs.2020.117717
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Planning Project of Shenzhen of China (JCYJ20170412140904406)
- Northwestern Polytechnical University (CX201969)
This publication has 121 references indexed in Scilit:
- Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT ReversalClinical Cancer Research, 2014
- Paradoxic effects of metformin on endothelial cells and angiogenesisCarcinogenesis: Integrative Cancer Research, 2014
- Metabolic targets for cancer therapyNature Reviews Drug Discovery, 2013
- Metformin inhibits lung cancer cells proliferation through repressing microRNA-222Biotechnology Letters, 2013
- Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cellsLeukemia, 2013
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine MetabolismCell, 2013
- Therapeutic effects of metformin in breast cancer: involvement of the immune system?Cancer Immunology, Immunotherapy, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Metformin and reduced risk of cancer in diabetic patientsBMJ, 2005
- The blooming of the French lilacJCI Insight, 2001